Multiple Sclerosis Medical Animation

Treating Multiple Sclerosis With Antihypertensive Drug
Researchers in Heidelberg and Stanford have discovered a new signalling pathway of brain cells that explains how widely used antihypertensive drugs could keep inflammation in multiple sclerosis (MS) in check. The peptide angiotensin not only raises blood pressure but also activates the immunological messenger substance TGF beta on a previously unknown communication pathway in the brain...

Mobility Loss Leads To Reduced Productivity And Earnings For People Living With Multiple Sclerosis
New research investigating how mobility impairment affects the lives of those with multiple sclerosis (MS) has found a substantial impact on workplace productivity and earnings. Almost three quarters (72%) of those surveyed said their mobility problems had a significant impact on their working lives and nearly two thirds (64%) reported losing earnings due to MS-related mobility issues...

FDA Grants Priority Review To Cladribine Tablets For The Treatment Of Relapsing Forms Of MS
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for Cladribine Tablets as a therapy for relapsing forms of multiple sclerosis (MS)...

Teva Comments On Generic Lovenox(R) Approval
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) commented on the U.S. Food and Drug Administration's response to a citizen petition questioning the approval criteria for a generic Lovenox® (enoxaparin sodium) injection and its subsequent approval of another generic filer's Abbreviated New Drug Application (ANDA)...

Symposium On Proposed Endovascular Treatment Of Chronic Cerebrospinal Venous Insufficiency
The Departments of Radiology and Neurology at SUNY Downstate Medical Center will hold a symposium on CCSVI (chronic cerebrospinal venous insufficiency) on Monday, July 26 from 9:00 am to 4:00 pm, in the Alumni Auditorium, 395 Lenox Road, Brooklyn, New York 11203. CCSVI is a syndrome in which blood flow from the brain is compromised...

Caltech Researchers Discover That Gut Bacteria Affect Multiple Sclerosis
Biologists at the California Institute of Technology (Caltech) have demonstrated a connection between multiple sclerosis (MS) - an autoimmune disorder that affects the brain and spinal cord - and gut bacteria. The work - led by Sarkis K...

Surveyed Neurologists' Awareness Of Merck Serono/EMD Serono's Oral Cladribine Is Double That Of Novartis/Mitsubishi Tanabe's FTY-720 (Gilenia)
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed neurologists have low awareness of Novartis/Mitsubishi Tanabe's FTY-720 (Gilenia) among the surveyed oral emerging therapies for the treatment of multiple sclerosis (MS)...

News From The Journal Of Clinical Investigation: July 12, 2010
IMMUNOLOGY: Drugs for high blood pressure of benefit in multiple sclerosis? The hormone angiotensin II (Ang II) is a key regulator of blood pressure. Drugs that block the molecules to which Ang II binds to mediate its effects (AT1Rs) are used to treat high blood pressure...

MultiCell Hires Clinical Research Organization To Manage MCT-125 Phase IIb Clinical Trial
MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) has retained Clinical Development & Support Services, Ltd. (CDSS) of Cheshire, England to manage its planned Phase IIb clinical trial in the United Kingdom for MCT-125, the Company's lead drug candidate for treatment of primary multiple sclerosis-related fatigue (PMSF)...

Breaching The Blood/Brain Barrier To Improve Treatment For Neurodegenerative Diseases
The University of South Florida's Department of Neurosurgery and Brain Repair has been granted a patent for a cell transplantation procedure combining human umbilical cord blood (HUCB) cells and a sugar-alcohol compound called "mannitol" that may make a big difference in treating life-threatening neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, multi...

Compugen Discovered Protein Shown To Abolish Recurring Relapses In Multiple Sclerosis Animal Model
Compugen Ltd. (NASDAQ:CGEN) announced that administration of CGEN-15001 in an animal model of multiple sclerosis (MS) has been shown to completely abolish spontaneous relapses. In addition, administration of this novel molecule prior to disease onset demonstrated a pronounced delay of disease onset and a significant decrease in disease symptoms...

Neurorehabilitation Symposium To Be Held In Atlanta In August
Scientists and engineers from around the globe will gather in August to share new information regarding neurorehabilitation advances for people with neurological movement disorders, including spinal cord and brain injures. The 2010 North American Neurorehabilitation Symposium is scheduled for Aug...

Brain Atrophy Responsible For Depression In People Battling Multiple Sclerosis
Adding to all that ails people managing their multiple sclerosis is depression for which MS sufferers have a lifetime risk as high as 50 percent. Yet despite its prevalence, the cause of this depression is not understood. It's not related to how severe one's MS is, and it can occur at any stage of the disease...

Cancer Drug Shows Promise For Treating A Wide Range Of Inflammatory Diseases
Those looking for a new treatment for a range of inflammatory diseases like arthritis, multiple sclerosis, inflammatory bowel disease, and lupus may need to look no further than a drug already available for treating cancer...

Clinical Trial Of New Multiple Sclerosis Treatment
Buffalo medical researchers led by a team from the University at Buffalo Department of Neurosurgery, will embark on a landmark prospective randomized double-blinded study to test the safety and efficacy of interventional endovascular therapy - dubbed "liberation treatment" - on the symptoms and progression of Multiple Sclerosis (MS)...